Endothelial cell infection and endotheliitis in COVID-19
By Z. Varga, A. Flammer, P. Steiger, M. Haberecker, Rea Andermatt, Annelies S. Zinkernagel, Mandeep R. Mehra, R. Schuepbach, F. Ruschitzka, H. Moch. The Lancet, 2020
5,643 citations recorded by the source corpus.
www.thelancet.com Published online April 17, 2020 https://doi.org/10.1016/S0140-6736(20)30937-5 1 ventilation. Echocardiography showed reduced left ventricular ejection fraction. Circulatory collapse ensued with mesenteric ischaemia, and small intestine resection was performed, but the patient survived. Histology of the small intestine resection revealed prominent endotheliitis of the submucosal vessels and apoptotic bodies (figure C). We found evidence of direct viral infection of the endothelial cell and diffuse endothelial inflammation. Although the virus uses ACE2 receptor expressed by pneumocytes in the epithelial alveolar lining to infect the host, thereby causing lung injury, the ACE2 receptor is also widely expressed on endothelial cells, which traverse multiple organs. Recruitment of immune cells, either by direct viral infection of the endothelium or immune-mediated, can result in widespread endothelial dysfunction associated with apoptosis (figure D). The vascular endothelium is an active paracrine, endocrine, and Endothelial cell infection and endotheliitis in COVID-19
Subfields: Epidemiology, Infectious Diseases, Oncology
View Paper: https://www.semanticscholar.org/paper/65b49592a3539c0c6a794ddfd2d623ab373c7a2b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Infectious Diseases
In Oncology
Citations in the corpus
- COVID-19 Image Data Collection: Prospective Predictions Are the Future (2020, methodology): “A recent hypothesis that is increasingly confirmed by research suggesting that COVID-19 is not a pulmonary but rather a vascular disease [Varga et al., 2020] [Ackermann et al.”
- Mechanisms of SARS-CoV-2 Transmission and Pathogenesis (2020, positive): “Recent evidence suggests that systemic inflammation induces long-term sequela in heart tissues [66,79,80,82,84,87,90,95].”
- COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection (2021, methodology): “These pre-existing comorbidities are associated with chronic endothelial dysfunction, so that SARS-CoV-2 may aggravate those conditions due to endotheliitis, apoptosis, and lymphocytic and mononuclear infiltrating cells [55, 91].”
- Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction (2020, result): “However, vasculitic changes of other organs or clinical findings related to systemic vasculitis were not seen, implying that the vasculitic changes could have developed in conjunction with severe bronchopneumonia, in contrast to a study that detected systemic vasculitis in COVID-19 patients.(32) A n”
- The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings (2020, background): “Indeed, a recent report described direct viral infection of the endothelial cell and diffuse endothelial inflammation in multiple organ systems (Varga et al., 2020).”
- Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis (2020, background): “While anti-inflammatory dietary constituents may be beneficial during hyper-inflammation, such as the COVID-19 cytokine storm, care should be taken against high doses of isolated anti-inflammatory compounds and/or antioxidants during healthier conditions in order to not suppress inflammation and the”
- Immunology of COVID-19: Current State of the Science (2020, positive): “Systemic and pulmonary thrombi have been reported with activation of the extrinsic coagulation cascade, involving dysfunctional endothelium and monocytic infiltration (Poor et al., 2020; Varga et al., 2020); thrombocytopenia and elevated D-dimer levels may be indicative of these coagulopathies in CO”